Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 1;17(5):286-292.
doi: 10.1097/COH.0000000000000755. Epub 2022 Jul 5.

HIV and cardiovascular disease: the role of inflammation

Sahera Dirajlal-Fargo  1   2 , Nicholas Funderburg  3
Affiliations
Review

HIV and cardiovascular disease: the role of inflammation

Sahera Dirajlal-Fargo et al. Curr Opin HIV AIDS. .

Abstract

Purpose of review: HIV and antiretroviral therapy (ART) use are linked to an increased incidence of atherosclerotic cardiovascular disease (ASCVD). Immune activation persists in ART-treated people with HIV (PWH), and markers of inflammation (i.e. IL-6, C-reactive protein) predict mortality in this population. This review discusses underlying mechanisms that likely contribute to inflammation and the development of ASCVD in PWH.

Recent findings: Persistent inflammation contributes to accelerated ASCVD in HIV and several new insights into the underlying immunologic mechanisms of chronic inflammation in PWH have been made (e.g. clonal haematopoiesis, trained immunity, lipidomics). We will also highlight potential pro-inflammatory mechanisms that may differ in vulnerable populations, including women, minorities and children.

Summary: Mechanistic studies into the drivers of chronic inflammation in PWH are ongoing and may aid in tailoring effective therapeutic strategies that can reduce ASCVD risk in this population. Focus should also include factors that lead to persistent disparities in HIV care and comorbidities, including sex as a biological factor and social determinants of health. It remains unclear whether ASCVD progression in HIV is driven by unique mediators (HIV itself, ART, immunodeficiency), or if it is an accelerated version of disease progression seen in the general population.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Dr. Funderburg has served a consultant and received support from Gilead.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV. Circulation. 2018;138(11):1100–12.

      Papers of particular interest, published recently, have been highlighted as: • Of importance

    1. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. The Journal of clinical endocrinology and metabolism. 2007;92(7):2506–12. - PMC - PubMed
    1. Gabuzda D, Jamieson BD, Collman RG, Lederman MM, Burdo TH, Deeks SG, et al. Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop. Pathog Immun. 2020;5(1):143–74. - PMC - PubMed
    1. Udo Hoffmann MTL, Borek Foldyna, Markella V. Zanni, Tricia H. Burdo, Carl Fichtenbaum, Turner E. Overton, Judith A Aberg, Judith S. Currier, Craig A. Sponseller, Kathleen Melbourne, Pamela S. Douglas, Heather J. Ribaudo0, Thomas Mayrhofer, Steven Grinspoon. CORONARY ARTERY DISEASE, TRADITIONAL RISK, AND INFLAMMATION AMONG PWH IN REPRIEVE. Conference on Retroviruses and Opportunistic Infections; Virtual2022.
    1. Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, et al. Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019;25(10):1576–88. - PMC - PubMed

Publication types